204 related articles for article (PubMed ID: 27699491)
21. Dissecting the interaction between transglutaminase 2 and fibronectin.
Cardoso I; Østerlund EC; Stamnaes J; Iversen R; Andersen JT; Jørgensen TJ; Sollid LM
Amino Acids; 2017 Mar; 49(3):489-500. PubMed ID: 27394141
[TBL] [Abstract][Full Text] [Related]
22. Identification of Isopeptides Between Human Tissue Transglutaminase and Wheat, Rye, and Barley Gluten Peptides.
Lexhaller B; Ludwig C; Scherf KA
Sci Rep; 2020 May; 10(1):7426. PubMed ID: 32367038
[TBL] [Abstract][Full Text] [Related]
23. Serologic assay for diagnosis of celiac disease based on a patient-derived monoclonal antigliadin antibody.
Steinsbø Ø; Dørum S; Lundin KE; Sollid LM
Gastroenterology; 2015 Nov; 149(6):1530-1540.e3. PubMed ID: 26208894
[TBL] [Abstract][Full Text] [Related]
24. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR
Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767
[TBL] [Abstract][Full Text] [Related]
25. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
26. Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.
Kerr C; Szmacinski H; Fisher ML; Nance B; Lakowicz JR; Akbar A; Keillor JW; Lok Wong T; Godoy-Ruiz R; Toth EA; Weber DJ; Eckert RL
Oncogene; 2017 May; 36(21):2981-2990. PubMed ID: 27941875
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate.
Han BG; Cho JW; Cho YD; Jeong KC; Kim SY; Lee BI
Int J Biol Macromol; 2010 Aug; 47(2):190-5. PubMed ID: 20450932
[TBL] [Abstract][Full Text] [Related]
28. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
[TBL] [Abstract][Full Text] [Related]
29. Transglutaminase 2 is expressed and active on the surface of human monocyte-derived dendritic cells and macrophages.
Hodrea J; Demény MA; Majai G; Sarang Z; Korponay-Szabó IR; Fésüs L
Immunol Lett; 2010 May; 130(1-2):74-81. PubMed ID: 20005901
[TBL] [Abstract][Full Text] [Related]
30. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
[TBL] [Abstract][Full Text] [Related]
31. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
[TBL] [Abstract][Full Text] [Related]
32. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
[TBL] [Abstract][Full Text] [Related]
33. Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects.
Paolella G; Nanayakkara M; Sposito S; Lepretti M; Auricchio S; Esposito C; Barone MV; Martucciello S; Caputo I
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059410
[TBL] [Abstract][Full Text] [Related]
34. Role of transglutaminase 2 in celiac disease pathogenesis.
Klöck C; Diraimondo TR; Khosla C
Semin Immunopathol; 2012 Jul; 34(4):513-22. PubMed ID: 22437759
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase.
Hausch F; Halttunen T; Mäki M; Khosla C
Chem Biol; 2003 Mar; 10(3):225-31. PubMed ID: 12670536
[TBL] [Abstract][Full Text] [Related]
36. Diversity of oat varieties in eliciting the early inflammatory events in celiac disease.
Silano M; Pozo EP; Uberti F; Manferdelli S; Del Pinto T; Felli C; Budelli A; Vincentini O; Restani P
Eur J Nutr; 2014 Aug; 53(5):1177-86. PubMed ID: 24240659
[TBL] [Abstract][Full Text] [Related]
37. Early tissue transglutaminase-mediated response underlies K562(S)-cell gliadin-dependent agglutination.
Silano M; Vincentini O; Luciani A; Felli C; Caserta S; Esposito S; Villella VR; Pettoello-Mantovani M; Guido S; Maiuri L
Pediatr Res; 2012 May; 71(5):532-8. PubMed ID: 22314661
[TBL] [Abstract][Full Text] [Related]
38. Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity.
Begg GE; Holman SR; Stokes PH; Matthews JM; Graham RM; Iismaa SE
J Biol Chem; 2006 May; 281(18):12603-9. PubMed ID: 16522628
[TBL] [Abstract][Full Text] [Related]
39. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of allosteric regulation of transglutaminase 2 by GTP.
Begg GE; Carrington L; Stokes PH; Matthews JM; Wouters MA; Husain A; Lorand L; Iismaa SE; Graham RM
Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19683-8. PubMed ID: 17179049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
